Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.
about
Clinical Trials in Branch Retinal Vein OcclusionBranch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy.Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial.Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment.Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trialsIncreased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion.[Retinal vein occlusion: Therapy of retinal vein occlusion].Anatomical and functional recurrence after dexamethasone intravitreal implants: a 6-month prospective studyHandheld-automated microsurgical instrumentation for intraocular laser surgery.Retro-Mode Scanning Laser Ophthalmoscopy Planning for Navigated Macular Laser Photocoagulation in Macular EdemaComparison of anti-vascular endothelial growth factors, laser treatments and a combination of the both for treatment of central retinal vein occlusionComparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study.Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis.Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series.Treatments for macular oedema following central retinal vein occlusion: systematic review.Sustained-release corticosteroid options.Recovery after cataract surgery.New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionDifferential effects of bevacizumab, ranibizumab and aflibercept on cell viability, phagocytosis and mitochondrial bioenergetics of retinal pigment epithelial cell.Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA.Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion.A 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion.Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa.Integrated results from the COPERNICUS and GALILEO studies.Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1.“Off-label” use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.Anti-vascular endothelial growth factor indications in ocular disease.Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion.Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B).Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.Postoperative endophthalmitis incidence after intravitreal therapy: a comparison of two different preoperative antibiotic prophylaxis.Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study.Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).The effects of commonly used intravitreal steroids on proliferation index of ciliary body-derived mesenchymal stem cells: an in vitro study.Intravitreal Injection of Bevacizumab: Review of our previous ExperienceUpdate in the Management of Macular Edema Following Retinal Vein Occlusions
P2860
Q26767092-3122215C-2C8F-4EB5-AABF-0876C74DCCF0Q33705988-B16B7879-34A5-492C-B49E-F517825662A1Q35209724-46F4851F-AE1A-4F04-8381-63B5BE034E4EQ35238074-D36A1AC0-FD88-4B7A-94F4-939A8518D2A9Q35405601-F92C0E4B-ABE0-4E39-81F2-6DBC1AEA216AQ35594036-10A20156-1E77-4ACD-B640-42CC467BF663Q35610722-CD3871EE-BAF8-4C96-9266-AAB5614A9165Q35737854-E21A562B-DF1E-4C78-A004-4F5D81AF3B87Q35748981-C3F1FA81-2DAD-41EF-9529-7F93EE11CA45Q35750150-5C268FF3-86B0-4502-8589-F990BE583F3EQ35962044-3BB2515C-154A-47FD-8239-72AC05EA6E74Q36011923-15E59727-E163-4CC0-A480-1A86180EE6F5Q36354007-E62DC5EA-B216-4BEE-9F55-3B677D8AF652Q36622491-200390A2-A26A-4AA9-8296-B3AD90E392CEQ36762577-2E660322-07C6-4690-B7EA-9586EDEA0866Q37530866-992117D3-8DCE-4131-B051-0FE3CFA93187Q37590692-B5EABF28-E0F3-470B-B0BD-8DFCC78BC764Q38241548-76C1D589-FC41-4E95-8A01-6000C105BE03Q38816679-C2F20128-FC2B-4A1B-B926-8E11944C109CQ38848800-267EED7F-CA58-48D5-8A7D-B14306FB7BC7Q38874774-D58D6213-CB4C-4900-8F9C-9B76B55E6743Q39136236-EF8E1119-A50A-4E45-B5FC-0CADB95186C4Q40022718-EFDB57DB-FE2D-4187-9FFB-D2A6BD403B64Q40523257-ABBBEB9D-C2EF-4E84-8A7A-945DCCBED76FQ41371210-C1337ABA-A8A9-4A84-9F00-AB6B670B6FD2Q41546137-E0E8F435-760B-47E1-BDBB-E6B28DE96E3CQ41622360-4A74A7FD-9CD9-438E-BDB3-75D2BA5B32A3Q47140209-DC407BED-583D-499B-AD3D-8CD96CD6C26EQ47147918-41469910-D7C5-48F7-A129-27FF105F835BQ48352897-E90FE7A2-8BDB-4A85-BB4A-7AA80C47D44DQ50592893-011FDBB8-F340-4077-A8D9-704C99D0717BQ50865919-96D5693B-0791-4830-887A-9203147A91FBQ51471678-40D40940-11AB-45AE-8EAC-31653C94FC8AQ51503406-77621B79-B7C1-455B-9444-87C9683AC383Q51537659-30B03461-41B8-435D-B1B0-06830C4F451DQ52857001-E01B3D35-5D0E-45F6-AE28-E2A2B703960DQ53386472-1D3E379C-E92E-48E3-BEFD-738ABC24E755Q53604386-14BDADC1-1F0C-4B58-8420-441DBE04ABA6Q57178289-60A857D1-5DAD-4287-8684-75297D3C0F0EQ57827814-6F222CCA-7291-409A-98C4-0B838D079834
P2860
Efficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic review.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Efficacy and safety of intravi ...... cclusion: a systematic review.
@ast
Efficacy and safety of intravi ...... cclusion: a systematic review.
@en
type
label
Efficacy and safety of intravi ...... cclusion: a systematic review.
@ast
Efficacy and safety of intravi ...... cclusion: a systematic review.
@en
prefLabel
Efficacy and safety of intravi ...... cclusion: a systematic review.
@ast
Efficacy and safety of intravi ...... cclusion: a systematic review.
@en
P2093
P2860
P1433
P1476
Efficacy and safety of intravi ...... cclusion: a systematic review.
@en
P2093
Bernd Junker
Christin Isserstedt
Josep Callizo
Nicolas Feltgen
P2860
P304
P356
10.1371/JOURNAL.PONE.0078538
P407
P5008
P577
2013-10-25T00:00:00Z